Position in ANAB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,517,469
+$11,930,566 QoQ
Shares Held
185,444
+291.6% QoQ
Ownership
0.637%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 211 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 94%
Shared 1%
None 5%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ANAB ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ANAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,517,469 | 185,444 | Shares | Sole | 2026-08-11 | |
| 2025-03-31 | $586,903 | 31,571 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $418,491 | 31,608 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,215,057 | 95,972 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,418,520 | 335,934 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,581,221 | 469,860 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,806,845 | 597,892 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $12,328,803 | 686,461 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $18,405,907 | 904,912 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $20,860,486 | 958,660 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,196,668 | 942,132 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $22,551,238 | 884,014 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $18,735,654 | 922,941 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $22,064,349 | 891,851 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,917,981 | 803,394 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $20,488,943 | 755,492 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,021,032 | 772,117 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,130,626 | 655,712 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,610,838 | 586,552 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $8,447,694 | 572,727 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,389,468 | 554,588 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,732,232 | 547,221 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||